News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Tubulis Achieves Key Milestone in BMS Strategic License Agreement as First Collaboration Tubutecan ADC Enters the Clinic
Wednesday, May 21, 2025Tubulis today announced that the first program from its strategic license agreement with Bristol Myers Squibb has entered clinical development triggering a significant milestone in the ongoing collaboration
Orion’s collaborator, MSD, expands clinical development program for opevesostat to women’s cancers
Wednesday, May 21, 2025Orions collaborator MSD has expanded the development program for opevestostat MK to now include womens cancers A new Phase clinical trial evaluating the safety and efficacy of opevesostat for the treatment of breast
Cellino’s iPSC Biomanufacturing Technology Receives FDA Advanced Manufacturing Technology Designation
Tuesday, May 20, 2025Cellino has received recognition from the US Food and Drug Administration FDA for its optical biomanufacturing technology used in the production of induced pluripotent stem cells iPSCs The companys platform has been granted
Novavax Gains U.S. FDA Approval for COVID-19 Vaccine
Tuesday, May 20, 2025Novavax Inc has received approval from the US Food and Drug Administration FDA for its Biologics License Application BLA for Nuvaxovid a proteinbased COVID vaccine The approval covers use in adults aged and above
IQVIA and SCRI Partner to Speed Up Global Cancer Trials
Saturday, May 17, 2025IQVIA a global leader in clinical research and healthcare intelligence has entered into a strategic partnership with SCRI Development Innovations the clinical research division of the Sarah Cannon Research Institute
PharmAla Biotech Introduces Phenesafe AI Platform for Discovery of Novel Phenethylamine Compounds
Friday, May 16, 2025PharmAla Biotech Holdings Inc a biotechnology firm dedicated to the research development and manufacturing of LaNeo MDMA and new derivatives within the MDXX compound class has officially launched its Phenesafe AI platform
Intelligent Bio Solutions Drives Global Growth of Fingerprint-Based Drug Testing
Friday, May 16, 2025Intelligent Bio Solutions Inc a medical technology company offering rapid noninvasive testing solutions has reported recent progress in expanding its global presence Growth has been driven by new client acquisitions
Renovaro Introduces Augusta, an AI-Powered Platform for Precision Neurology
Thursday, May 15, 2025Renovaro Inc a company focused on AIdriven precision medicine for cancer and neurological conditions has introduced Augusta a new platform designed to improve diagnosis treatment and research in neurology
FDA Grants Seven-Year Orphan-Drug Exclusivity for Ryoncil®
Thursday, May 15, 2025Mesoblast a global company specialising in allogeneic cellular medicines for inflammatory diseases has received seven years of orphandrug exclusivity from the US Food and Drug Administration FDA for its product Ryoncil remestemcelL This approval cove...
CellFE and Made Scientific Partner to Advance Non-Viral Gene Editing in T Cell Therapies
Wednesday, May 14, 2025CellFE a specialist in microfluidicsbased cell engineering has entered a strategic collaboration with Made Scientific a contract development and manufacturing organisation CDMO focused on cell therapies
